Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amino acids + chromium picolinate is a combination product typically marketed as a dietary supplement. **Chromium picolinate** is a coordination complex of chromium(III) and picolinic acid, widely used for its purported role in potentiating insulin action and influencing carbohydrate, protein, and fat metabolism[2][3][4]. The **amino acids** in such products often refer to a subset proposed to be part of the so-called “glucose tolerance factor” (GTF), usually including glycine, cysteine, glutamic acid, and occasionally aspartate[1][3][4]. Chromium picolinate’s biological effects are mainly through supposed increased sensitivity and activity of insulin receptors, although robust clinical benefit remains unproven[2][3]. This combination is generally used as a **dietary supplement** for blood sugar support or weight management, but comprehensive clinical efficacy data are lacking; most claims have not been substantiated in large, well-controlled trials[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acids + chromium picolinate.